Literature DB >> 15888983

Acute transverse myelitis and hepatitis C virus.

Pasquale Annunziata1, Massimo Marroni, Daniela Francisci, Giuliano Stagni.   

Abstract

In the last few years, substantial evidence has been provided on peripheral nervous involvement in infection by hepatitis C virus (HCV), whilst central nervous involvement is rare. Here, we report a case of acute transverse myelitis in a woman developing 4 years after documented HCV seropositivity, associated with intrathecal anti-HCV protein IgG. Isoelectrofocusing of all CSF samples before and after immunoabsorption with recombinant structural HCV proteins revealed disappearance or marked decrease of some oligoclonal IgG bands suggesting binding to HCV proteins. To our knowledge, this is the first report of acute myelitis associated with intrathecal immune response against HCV proteins. This finding suggests that in acute myelitis of unknown aetiology, testing CSF for HCV RNA and related antibodies is warranted.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15888983

Source DB:  PubMed          Journal:  Infez Med        ISSN: 1124-9390


  4 in total

1.  Neurotoxic effects of the HCV core protein are mediated by sustained activation of ERK via TLR2 signaling.

Authors:  Amy D Paulino; Kiren Ubhi; Edward Rockenstein; Anthony Adame; Leslie Crews; Scott Letendre; Ronald Ellis; Ian P Everall; Igor Grant; Eliezer Masliah
Journal:  J Neurovirol       Date:  2011-06-10       Impact factor: 2.643

2.  Acute myelitis associated with HCV infection.

Authors:  Kentaro Suzuki; Masaki Takao; Yasuo Katayama; Ban Mihara
Journal:  BMJ Case Rep       Date:  2013-06-13

3.  A case of acute disseminated encephalomyelitis associated with hepatitis C virus infection.

Authors:  Jae Eun Sim; Jun-Bum Lee; Yu Na Cho; Sang Hyun Suh; Ja Kyung Kim; Kyung-Yul Lee
Journal:  Yonsei Med J       Date:  2012-07-01       Impact factor: 2.759

Review 4.  HCV-related central and peripheral nervous system demyelinating disorders.

Authors:  Sara Mariotto; Sergio Ferrari; Salvatore Monaco
Journal:  Inflamm Allergy Drug Targets       Date:  2014
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.